About Ataraxis AI

Ataraxis is an AI precision medicine company working at the intersection of multi-modal artificial intelligence and oncology. We develop and deploy AI-native tools to assist physicians in selecting the most optimal treatments for their patients.

Our mission is to change how cancer is treated and impact at least 50% of new cancer cases by 2030. We have already launched our first products, including the Ataraxis™ Breast platform for breast cancer, and help cancer patients get the most appropriate treatment every day. We work with the best academic institutions in the United States as well as small community clinics to deliver better care with frontier technology.

At Ataraxis, you will have a unique opportunity to shape not only the future of our company, but also the future of healthcare. You will join an exceptional team at the forefront of healthcare-focused AI research and deployment. As a frontier AI lab, we bring together leading AI researchers, medical doctors, and industry veterans. Our advisors include AI pioneers such as Yann LeCun and distinguished oncologists from top cancer research institutions, all united by the mission to redefine precision medicine.

Ataraxis has raised $24 million in funding, including a $20.4 million Series A in early 2025 led by top venture capital funds such as AIX Ventures (Hugging Face, Perplexity), Thiel Capital, Founders Fund (OpenAI, SpaceX, Palantir, Oscar Health), and Obvious Ventures (Recursion).

We are an company with a flat organizational structure, where every team member is empowered to actively contribute. Leadership roles are earned by those who demonstrate initiative and consistently deliver exceptional results. Strong work ethic and the ability to prioritize ruthlessly are essential.

Responsibilities

• Aggressively drive sales growth and market penetration of Ataraxis oncology products through direct sales to individual oncologists within your designated territory.

• Prospecting new business and maintaining relationships.

Qualifications

• Minimum 2 years of demonstrated high-performance sales experience in oncology, especially in breast cancer.

• Proven track record of consistently exceeding sales quotas and demonstrated achievement through awards or recognition (e.g., President's Club, Rookie of the Year).

• Passionate about AI and innovation in healthcare, driven to learn and effectively communicate AI-based diagnostic solutions.

• Autonomous, capable of excelling independently in a hyper-growth start-up environment.

• Ability to thrive in a highly competitive environment; demonstrates resilience, urgency, and focus on closing deals.

Compensation for this role includes a base salary plus variable commission, with OTE ranging from $230,000–$250,000. Equity and benefits are also included.